Cue Biopharma Stock (NASDAQ: CUE) stock price, news, charts, stock research, profile.
You can purchase shares of Cue Biopharma (NASDAQ:CUE) through any online brokerage.
Other companies in Cue Biopharma’s space includes: Burning Rock Biotech (NASDAQ:BNR), Immuneering (NASDAQ:IMRX), Armata Pharmaceuticals (AMEX:ARMP), Inovio Pharmaceuticals (NASDAQ:INO) and Vistagen Therapeutics (NASDAQ:VTGN).
Cue Biopharma has a consensus price target of $8.71.
The stock price for Cue Biopharma (NASDAQ: CUE) is $1.01 last updated December 20, 2024 at 4:21 PM EST.
There are no upcoming dividends for Cue Biopharma.
Cue Biopharma’s Q4 earnings are confirmed for Monday, March 10, 2025.
There is no upcoming split for Cue Biopharma.
Cue Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.